抗白血病治愈的骨髓祖细胞样细胞。 - Suppr

Suppr

超能文献

Bone marrow progenitor-like cells against leukemia cure.

作者信息

Elitzur Sarah, Izraeli Shai

机构信息

Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel.

出版信息

Nat Cancer. 2025 Jan;6(1):18-19. doi: 10.1038/s43018-024-00864-4.

DOI:10.1038/s43018-024-00864-4

PMID:39587258

Abstract

摘要

相似文献

Bone marrow progenitor-like cells against leukemia cure.抗白血病治愈的骨髓祖细胞样细胞。

Nat Cancer. 2025 Jan;6(1):18-19. doi: 10.1038/s43018-024-00864-4.

Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.氨磷汀可提高马磷酰胺的抗白血病治疗指数：对骨髓净化的意义。

Blood. 1995 Oct 1;86(7):2849-55.

[Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].利用特异性靶向WT1衍生肽的细胞毒性T淋巴细胞消除白血病CD34 +祖细胞：体外实验研究

Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3401-6.

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.急性淋巴细胞白血病骨髓移植后，白血病祖细胞的移植前负荷作为复发的预测指标

N Engl J Med. 1993 Oct 28;329(18):1296-301. doi: 10.1056/NEJM199310283291802.

Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.重组人肿瘤坏死因子对来自正常人骨髓、外周血以及慢性髓性白血病患者骨髓的高度富集造血祖细胞群体的影响。

Cancer Res. 1987 Sep 15;47(18):4788-94.

Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.用硫代磷酸酯寡核苷酸OL(1)p53对骨髓进行体外处理，用于急性髓性白血病和骨髓增生异常综合征的自体移植。

J Hematother. 1997 Oct;6(5):441-6. doi: 10.1089/scd.1.1997.6.441.

Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.白藜芦醇选择性抑制白血病细胞：一种用于体外骨髓净化的潜在药物。

Bone Marrow Transplant. 2000 Mar;25(6):639-45. doi: 10.1038/sj.bmt.1702189.

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.急性髓系白血病患者的骨髓间充质基质细胞表现出脂肪生成分化倾向，这对白血病细胞的支持具有重要意义。

Leukemia. 2020 Feb;34(2):391-403. doi: 10.1038/s41375-019-0568-8. Epub 2019 Sep 6.

Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice.骨髓造血干细胞/祖细胞区室中经典和造血特异性p53途径的改变促进了实验小鼠白血病的进展。

Leuk Res. 2016 Aug;47:70-7. doi: 10.1016/j.leukres.2016.05.014. Epub 2016 May 24.

Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.来自Fv-4抗性供体的骨髓移植可使感染Friend白血病病毒的小鼠免于白血病：一种针对逆转录病毒感染的骨髓移植治疗模型。

Leukemia. 1994 Dec;8(12):2200-6.

本文引用的文献

A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.一项多组学图谱研究确定了T细胞急性淋巴细胞白血病中一种耐药的、骨髓祖细胞样细胞群。

Nat Cancer. 2025 Jan;6(1):102-122. doi: 10.1038/s43018-024-00863-5. Epub 2024 Nov 25.

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.儿童 T 细胞系急性淋巴细胞白血病的基因组基础。

Nature. 2024 Aug;632(8027):1082-1091. doi: 10.1038/s41586-024-07807-0. Epub 2024 Aug 14.

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.T-ALL 中 ETP 表型和微小残留病的预后意义：一项儿童肿瘤学组研究。

Blood. 2023 Dec 14;142(24):2069-2078. doi: 10.1182/blood.2023020678.

MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus.MEF2C 抑制淋巴谱系决定并驱动胸腺中的白血病。

JCI Insight. 2022 Jul 8;7(13):e150363. doi: 10.1172/jci.insight.150363.

Kinase Inhibition as Treatment for Acute and Chronic Graft--Host Disease.激酶抑制作为急性和慢性移植物抗宿主病的治疗方法。

Front Immunol. 2021 Nov 17;12:760199. doi: 10.3389/fimmu.2021.760199. eCollection 2021.

Bruton's Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures.布鲁顿酪氨酸激酶（BTK）抑制剂与自身免疫性疾病：解析 BTK 抑制剂的特异性特征及近期临床试验的成败。

Front Immunol. 2021 Nov 3;12:662223. doi: 10.3389/fimmu.2021.662223. eCollection 2021.

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.ETV6-NCOA2 融合通过转化非胸腺造血祖细胞诱导 T/髓系混合表型白血病。

Blood. 2022 Jan 20;139(3):399-412. doi: 10.1182/blood.2020010405.

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.基于网络的系统药理学揭示了LCK和BCL2信号通路的异质性以及T细胞急性淋巴细胞白血病的治疗敏感性。

Nat Cancer. 2021 Mar;2(3):284-299. doi: 10.1038/s43018-020-00167-4. Epub 2021 Jan 21.

Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development.新型布鲁顿酪氨酸激酶（BTK）小分子抑制剂：当前的研发进展。

Eur J Med Chem. 2021 May 5;217:113329. doi: 10.1016/j.ejmech.2021.113329. Epub 2021 Mar 12.

Programming for T-lymphocyte fates: modularity and mechanisms.T 淋巴细胞命运的编程：模块化和机制。

Genes Dev. 2019 Sep 1;33(17-18):1117-1135. doi: 10.1101/gad.327163.119.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验